Stryker Corporation (NYSE:SYK) is scheduled to announce its earnings results after the market closes on Thursday, October 26th. Analysts expect the company to announce earnings of $1.52 per share for the quarter. Stryker Corporation has set its Q3 guidance at $1.50-1.55 EPS and its FY17 guidance at $6.45-6.55 EPS.
Stryker Corporation (NYSE:SYK) last released its earnings results on Thursday, July 27th. The medical technology company reported $1.53 earnings per share for the quarter, beating analysts’ consensus estimates of $1.51 by $0.02. Stryker Corporation had a net margin of 14.22% and a return on equity of 24.26%. The company had revenue of $3.01 billion for the quarter, compared to analysts’ expectations of $2.98 billion. During the same quarter in the previous year, the company earned $1.39 EPS. Stryker Corporation’s revenue for the quarter was up 6.1% on a year-over-year basis. On average, analysts expect Stryker Corporation to post $6.45 EPS for the current fiscal year and $7.09 EPS for the next fiscal year.
Stryker Corporation (NYSE SYK) opened at 148.64 on Thursday. The company’s 50 day moving average is $143.70 and its 200-day moving average is $140.89. The stock has a market cap of $55.60 billion, a PE ratio of 33.18 and a beta of 0.80. Stryker Corporation has a 1-year low of $106.48 and a 1-year high of $150.00.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, October 31st. Investors of record on Friday, September 29th will be issued a dividend of $0.425 per share. This represents a $1.70 dividend on an annualized basis and a yield of 1.14%. The ex-dividend date of this dividend is Thursday, September 28th. Stryker Corporation’s dividend payout ratio (DPR) is presently 37.95%.
A number of brokerages recently issued reports on SYK. Zacks Investment Research downgraded shares of Stryker Corporation from a “buy” rating to a “hold” rating in a report on Thursday, August 17th. BidaskClub downgraded shares of Stryker Corporation from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Cowen and Company set a $160.00 price target on shares of Stryker Corporation and gave the stock a “buy” rating in a report on Friday, October 6th. Oppenheimer Holdings, Inc. set a $148.00 price target on shares of Stryker Corporation and gave the stock a “hold” rating in a report on Friday, July 28th. Finally, Jefferies Group LLC reissued a “hold” rating and set a $132.00 price target on shares of Stryker Corporation in a report on Friday, June 30th. Three investment analysts have rated the stock with a sell rating, eight have issued a hold rating and twelve have given a buy rating to the company’s stock. Stryker Corporation currently has a consensus rating of “Hold” and an average price target of $146.78.
In related news, insider Lonny J. Carpenter sold 5,000 shares of the firm’s stock in a transaction dated Friday, August 4th. The shares were sold at an average price of $146.36, for a total transaction of $731,800.00. Following the completion of the sale, the insider now directly owns 88,207 shares in the company, valued at $12,909,976.52. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Graham A. Mclean sold 1,124 shares of the firm’s stock in a transaction dated Tuesday, August 8th. The stock was sold at an average price of $146.26, for a total transaction of $164,396.24. Following the sale, the insider now owns 8,983 shares of the company’s stock, valued at $1,313,853.58. The disclosure for this sale can be found here. Company insiders own 7.40% of the company’s stock.
Stryker Corporation Company Profile
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.